Last 7 days
-7.9%
Last 30 days
-5.8%
Last 90 days
-23.7%
Trailing 12 Months
5.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-30 | Kolli Sreelakshmi | bought | 120,370 | 120 | 1,000 | - |
2023-08-28 | HAGEMANN ROBERT | bought | 232,960 | 116 | 2,000 | - |
2023-08-25 | BERNARD BETSY J | bought | 100,023 | 114 | 871 | - |
2023-08-25 | MICHELSON MICHAEL W | bought | 150,150 | 115 | 1,300 | - |
2023-08-23 | HIGGINS ARTHUR J | bought | 115,613 | 115 | 1,000 | - |
2023-07-01 | VAN ZUILEN WILFRED | acquired | - | - | 2,633 | pres, europe, m. east & africa |
2023-07-01 | Upadhyay Suketu | sold (taxes) | -245,697 | 146 | -1,677 | exec. vp, cfo |
2023-07-01 | Upadhyay Suketu | acquired | - | - | 3,768 | exec. vp, cfo |
2023-06-01 | Stellato Paul A | sold (taxes) | -25,056 | 127 | -197 | vp, controller & cao |
2023-06-01 | Stellato Paul A | acquired | - | - | 628 | vp, controller & cao |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | sold off | -100 | -11,057,600 | - | -% |
2023-09-21 | Jefferies Group LLC | new | - | 810,263 | 810,263 | 0.01% |
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 1,789 | 15,666 | -% |
2023-09-20 | BARCLAYS PLC | added | 89.02 | 36,139,000 | 68,115,000 | 0.04% |
2023-09-12 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | sold off | -100 | -1,938,000 | - | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 67.14 | 23,974 | 51,106 | 0.01% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 10,634,300 | 10,634,300 | 0.56% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | -4,002 | 80,685 | 0.01% |
2023-08-25 | EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC | added | 0.58 | 3,068,000 | 26,046,000 | 3.59% |
2023-08-24 | Alberta Investment Management Corp | reduced | -79.96 | -19,202,800 | 5,600,650 | 0.05% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 5.3% | 11,200,109 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 11.46% | 24,055,739 | SC 13G/A | |
Jan 30, 2023 | blackrock inc. | 10.4% | 21,803,709 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 10.4% | 21,803,709 | SC 13G/A | |
Apr 08, 2022 | vanguard group inc | 11.04% | 23,102,761 | SC 13G/A | |
Jan 28, 2022 | jpmorgan chase & co | 5.4% | 11,340,168 | SC 13G | |
Jan 28, 2022 | blackrock inc. | 10.4% | 21,793,439 | SC 13G/A | |
Apr 12, 2021 | blackrock inc. | 10.0% | 20,926,542 | SC 13G/A | |
Feb 11, 2021 | massachusetts financial services co /ma/ | 4.8% | 10,001,947 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 7.58% | 15,703,785 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 29, 2023 | 4 | Insider Trading | |
Aug 29, 2023 | 4 | Insider Trading | |
Aug 25, 2023 | 4 | Insider Trading | |
Aug 22, 2023 | 8-K | Current Report | |
Aug 01, 2023 | 10-Q | Quarterly Report | |
Aug 01, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MDT | 104.1B | 31.6B | -3.89% | -3.30% | 28.69 | 3.3 | 1.57% | -30.40% |
ISRG | 102.4B | 6.7B | -3.33% | 56.36% | 71.85 | 15.36 | 11.75% | -0.66% |
SYK | 101.2B | 19.5B | -4.23% | 31.95% | 37.36 | 5.2 | 10.36% | 30.30% |
BDX | 71.3B | 19.0B | -8.08% | 14.20% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.6B | 5.7B | -7.79% | -14.88% | 30.67 | 7.53 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 9.2B | 937.8M | -4.69% | 30.64% | 316.65 | 9.84 | 16.30% | 250.21% |
SWAV | 7.3B | 616.6M | -6.84% | -23.46% | 30.01 | 11.87 | 69.52% | 343.68% |
GMED | 5.0B | 1.1B | -7.21% | -13.95% | 23.85 | 4.57 | 12.63% | 50.85% |
IRTC | 2.8B | 452.1M | -9.56% | -23.21% | -28.09 | 6.17 | 24.99% | 24.09% |
TNDM | 1.4B | 790.3M | -20.84% | -55.28% | -6.03 | 1.71 | 3.21% | -1604.53% |
SMALL-CAP | ||||||||
AVNS | 955.9M | 780.7M | -5.94% | -5.33% | -26.55 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
BLFS | 610.4M | 162.2M | 26.12% | -37.36% | -7.26 | 3.76 | 9.71% | 12.37% |
SILK | 590.7M | 162.9M | -24.99% | -65.29% | -11.17 | 3.63 | 42.67% | 12.82% |
4%
-1.1%
-2.3%
-5.2%
70.4%
34.6%
18.5%
Y-axis is the maximum loss one would have experienced if Zimmer Biomet Holdings was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 1.2% | 7,196 | 7,108 | 6,940 | 6,892 | 6,908 | 6,889 | 6,827 | 7,135 | 7,379 | 6,842 | 7,025 | 7,065 | 7,028 | 7,791 | 7,982 | 7,928 | 7,872 | 7,891 | 7,933 | 7,930 | 7,907 |
S&GA Expenses | 1.1% | 2,824 | 2,793 | 2,762 | 2,840 | 2,869 | 2,871 | 2,843 | 2,467 | 2,573 | 2,541 | 2,713 | 2,632 | 2,669 | 2,843 | 2,810 | 3,460 | 3,422 | 3,374 | 3,379 | 3,246 | 3,170 |
EBITDA | -100.0% | - | 1,342 | 1,165 | 1,155 | 1,050 | 1,167 | 1,277 | 1,599 | 1,685 | 1,285 | 546 | 629 | 548 | 902 | 1,685 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.19* | 0.17* | 0.17* | 0.15* | 0.15* | 0.16* | 0.21* | 0.22* | 0.18* | 0.08* | 0.09* | 0.08* | 0.12* | 0.21* | - | - | - | - | - | - |
Interest Expenses | -7.4% | -184 | -171 | -164 | -171 | -181 | -197 | -208 | -212 | -214 | -213 | -212 | -211 | -214 | -219 | -227 | -243 | -253 | -269 | -289 | -793 | -643 |
Earnings Before Taxes | 13.1% | 666 | 589 | 404 | 394 | 408 | 386 | 499 | 948 | 1,013 | 613 | -105 | -206 | -277 | 85.00 | 880 | -249 | -280 | -202 | -271 | 471 | 444 |
EBT Margin | -100.0% | - | 0.08* | 0.06* | 0.06* | 0.04* | 0.04* | 0.05* | 0.10* | 0.11* | 0.06* | -0.04* | -0.03* | -0.04* | 0.01* | 0.11* | - | - | - | - | - | - |
Net Income | 12.4% | 506 | 450 | 231 | 278 | 230 | 218 | 402 | 819 | 916 | 568 | -138 | -151 | 37.00 | 377 | 1,132 | -90.20 | -359 | -307 | -379 | 1,753 | 1,690 |
Net Income Margin | -100.0% | - | 0.06* | 0.03* | 0.04* | 0.03* | 0.03* | 0.05* | 0.11* | 0.12* | 0.08* | -0.02* | -0.02* | 0.01* | 0.05* | 0.14* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 1,150 | 1,168 | 1,276 | 1,294 | 1,416 | 1,356 | 1,428 | 1,399 | 895 | 1,087 | 1,061 | 1,230 | 1,544 | 1,379 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 0.2% | 21,294 | 21,244 | 21,066 | 21,333 | 21,453 | 21,618 | 23,456 | 24,009 | 24,223 | 24,027 | 24,418 | 24,026 | 23,648 | 25,513 | 24,639 | 24,315 | 24,206 | 24,289 | 24,127 | 25,382 | 25,491 |
Current Assets | -0.5% | 4,388 | 4,412 | 4,427 | 4,534 | 4,463 | 4,517 | 4,885 | 5,312 | 5,357 | 5,000 | 5,083 | 5,153 | 4,707 | 6,371 | 4,724 | 4,402 | 4,391 | 4,499 | 4,427 | 4,513 | 4,475 |
Cash Equivalents | -3.1% | 320 | 330 | 376 | 545 | 386 | 436 | 378 | 920 | 1,042 | 724 | 775 | 967 | 713 | 2,434 | 618 | 513 | 403 | 587 | 543 | 525 | 481 |
Inventory | 1.5% | 2,276 | 2,241 | 2,147 | 2,129 | 2,123 | 2,132 | 2,148 | 2,517 | 2,533 | 2,512 | 2,174 | 2,492 | 2,497 | 2,463 | 2,385 | 2,362 | 2,345 | 2,310 | 2,257 | 2,220 | 2,159 |
Net PPE | 3.6% | 1,975 | 1,906 | 1,873 | 1,802 | 1,797 | 1,826 | 1,837 | 2,008 | 2,005 | 2,022 | 1,864 | 2,043 | 2,057 | 2,066 | 2,077 | 2,055 | 2,036 | 2,014 | 2,015 | 2,002 | 1,987 |
Goodwill | 0.1% | 8,744 | 8,735 | 8,580 | 8,799 | 8,869 | 8,896 | 8,919 | 9,212 | 9,248 | 9,233 | 8,983 | 9,039 | 8,982 | 8,951 | 9,197 | 9,545 | 9,594 | 9,570 | 9,594 | 10,584 | 10,596 |
Liabilities | -1.9% | 8,916 | 9,086 | 9,039 | 9,082 | 9,328 | 9,596 | 10,790 | 11,294 | 11,640 | 11,577 | 12,218 | 12,147 | 12,004 | 13,630 | 12,246 | 12,230 | 12,544 | 12,750 | 12,851 | 13,159 | 13,447 |
Current Liabilities | -4.4% | 2,234 | 2,336 | 2,358 | 2,296 | 2,464 | 2,674 | 3,468 | 2,939 | 2,929 | 2,089 | 2,557 | 2,266 | 2,161 | 3,780 | 3,442 | 3,774 | 3,678 | 2,255 | 2,421 | 2,391 | 1,854 |
LT Debt, Current | -11.1% | 520 | 585 | 544 | 659 | 852 | 1,015 | 1,605 | 1,046 | 1,050 | 300 | 500 | 450 | 450 | 1,950 | 1,500 | 2,000 | 2,000 | 500 | 525 | 600 | 100 |
LT Debt, Non Current | -0.3% | 5,189 | 5,205 | 5,152 | 5,055 | 5,172 | 5,286 | 5,464 | 6,458 | 6,803 | 7,539 | 7,627 | 7,840 | 7,759 | 7,724 | 6,721 | 6,346 | 6,719 | 8,311 | 8,414 | 8,597 | 9,413 |
Shareholder's Equity | 1.8% | 12,372 | 12,158 | 12,020 | 12,245 | 12,125 | 12,021 | 12,666 | 12,714 | 12,583 | 12,450 | 12,199 | 11,878 | 11,644 | 11,883 | 12,393 | 12,086 | 11,662 | 11,539 | 11,276 | 12,223 | 12,044 |
Retained Earnings | 1.6% | 9,902 | 9,742 | 9,559 | 9,740 | 9,607 | 9,503 | 10,292 | 10,426 | 10,331 | 10,238 | 10,087 | 9,803 | 9,610 | 9,866 | 10,427 | 10,155 | 9,773 | 9,688 | 9,491 | 10,441 | 10,328 |
Additional Paid-In Capital | 0.8% | 9,766 | 9,692 | 9,504 | 9,464 | 9,419 | 9,386 | 9,315 | 9,295 | 9,249 | 9,199 | 9,122 | 9,073 | 9,014 | 8,984 | 8,920 | 8,867 | 8,777 | 8,748 | 8,686 | 8,662 | 8,597 |
Shares Outstanding | -0.4% | 209 | 209 | - | 210 | 210 | 209 | - | 209 | 209 | 208 | - | 212 | 212 | 212 | - | 211 | 210 | 210 | - | 209 | 208 |
Minority Interest | 2.9% | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 6.00 | 3.00 | 4.00 | 5.00 | 4.00 | 3.00 | 5.00 | 5.00 | 6.00 | 1.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 0.2% | 1,351 | 1,348 | 1,356 | 1,450 | 1,423 | 1,497 | 1,404 | 1,363 | 1,320 | 848 | 1,076 | 1,007 | 1,203 | 1,557 | 1,390 | 1,542 | 1,448 | 1,541 | 1,747 | 1,771 | 1,750 |
Share Based Compensation | 5.9% | 113 | 107 | 105 | 93.00 | 84.00 | 79.00 | 76.00 | 73.00 | 78.00 | 77.00 | 74.00 | 78.00 | 76.00 | 73.00 | 77.00 | 82.00 | 80.00 | 72.00 | 66.00 | 59.00 | 52.00 |
Cashflow From Investing | 0.0% | -590 | -590 | -522 | -533 | -560 | -416 | -443 | -585 | -564 | -551 | -564 | -351 | -423 | -660 | -644 | -673 | -649 | -420 | -416 | -462 | -444 |
Cashflow From Financing | 4.3% | -823 | -860 | -775 | -1,118 | -1,350 | -1,232 | -1,306 | -934 | -551 | -2,108 | -420 | -315 | -571 | 850 | -777 | -872 | -872 | -2,279 | -1,302 | -1,259 | -1,282 |
Dividend Payments | 0% | 201 | 201 | 201 | 201 | 201 | 201 | 200 | 200 | 199 | 199 | 199 | 198 | 198 | 197 | 197 | 196 | 196 | 196 | 195 | 195 | 195 |
Buy Backs | -47.3% | 564 | 1,070 | 126 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Net Sales | $ 1,869.6 | $ 1,781.8 | $ 3,700.6 | $ 3,445.0 |
Type of Revenue [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember |
Cost of products sold, excluding intangible asset amortization | $ 525.5 | $ 511.0 | $ 1,026.3 | $ 1,011.0 |
Type of Cost, Good or Service [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember |
Intangible asset amortization | $ 138.2 | $ 133.0 | $ 271.6 | $ 263.8 |
Research and development | 118.1 | 99.4 | 228.5 | 196.3 |
Selling, general and administrative | 725.8 | 695.2 | 1,441.8 | 1,379.7 |
Intangible asset impairment | 3.0 | 3.0 | ||
Restructuring and other cost reduction initiatives | 24.4 | 57.0 | 66.3 | 100.9 |
Quality remediation | 7.8 | 14.3 | ||
Acquisition, integration, divestiture and related | 7.9 | (5.5) | 9.1 | (3.3) |
Operating expenses | 1,539.9 | 1,500.9 | 3,043.6 | 2,965.7 |
Operating Profit | 329.6 | 280.9 | 656.9 | 479.3 |
Other (expense) income, net | (1.2) | (42.6) | 6.5 | (98.7) |
Interest expense, net | (51.6) | (38.8) | (99.8) | (79.9) |
Earnings from continuing operations before income taxes | 276.8 | 199.5 | 563.6 | 300.7 |
Provision for income taxes from continuing operations | 66.9 | 45.5 | 121.0 | 73.5 |
Net Earnings from continuing operations | 209.9 | 154.0 | 442.6 | 227.2 |
Less: Net earnings attributable to noncontrolling interest | 0.2 | 0.3 | 0.5 | 0.5 |
Net Earnings from Continuing Operations of Zimmer Biomet Holdings, Inc. | 209.6 | 153.7 | 442.1 | 226.7 |
Loss from discontinued operations, net of taxes | (58.8) | |||
Net Earnings of Zimmer Biomet Holdings, Inc. | $ 209.6 | $ 153.7 | $ 442.1 | $ 167.9 |
Earnings Per Common Share - Basic | ||||
Earnings from continuing operations | $ 1.00 | $ 0.73 | $ 2.12 | $ 1.08 |
Loss from discontinued operations | (0.28) | |||
Net Earnings Per Common Share - Basic | 1.00 | 0.73 | 2.12 | 0.80 |
Earnings Per Common Share - Diluted | ||||
Earnings from continuing operations | 1.00 | 0.73 | 2.10 | 1.08 |
Loss from discontinued operations | (0.28) | |||
Net Earnings Per Common Share - Diluted | $ 1.00 | $ 0.73 | $ 2.10 | $ 0.80 |
Weighted Average Common Shares Outstanding | ||||
Basic | 208.6 | 209.6 | 209.0 | 209.4 |
Diluted | 209.9 | 210.3 | 210.1 | 210.2 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 319.8 | $ 375.7 |
Accounts receivable, less allowance for credit losses | 1,367.3 | 1,381.5 |
Inventories | 2,275.8 | 2,147.2 |
Prepaid expenses and other current assets | 425.1 | 522.9 |
Total Current Assets | 4,387.9 | 4,427.3 |
Property, plant and equipment, net | 1,975.0 | 1,872.5 |
Goodwill | 8,743.7 | 8,580.2 |
Intangible assets, net | 5,027.7 | 5,063.8 |
Other assets | 1,160.0 | 1,122.2 |
Total Assets | 21,294.3 | 21,066.0 |
Current Liabilities: | ||
Accounts payable | 354.6 | 354.1 |
Income taxes payable | 81.6 | 38.5 |
Other current liabilities | 1,277.6 | 1,421.3 |
Current portion of long-term debt | 520.0 | 544.3 |
Total Current Liabilities | 2,233.7 | 2,358.2 |
Deferred income taxes, net | 474.9 | 474.8 |
Long-term income tax payable | 375.7 | 421.2 |
Other long-term liabilities | 642.0 | 632.6 |
Long-term debt | 5,189.4 | 5,152.2 |
Total Liabilities | 8,915.8 | 9,039.0 |
Commitments and Contingencies (Note 16) | ||
Stockholders' Equity: | ||
Common stock, $0.01 par value, one billion shares authorized, 315.8 million shares as of June 30, 2023 (313.8 million as of December 31, 2022) issued | 3.2 | 3.1 |
Paid-in capital | 9,766.0 | 9,504.4 |
Retained earnings | 9,902.3 | 9,559.3 |
Accumulated other comprehensive loss | (177.8) | (179.3) |
Treasury stock, 107.0 million shares as of June 30, 2023 (104.8 million as of December 31, 2022) | (7,122.2) | (6,867.2) |
Total Zimmer Biomet Holdings, Inc. stockholders' equity | 12,371.5 | 12,020.3 |
Noncontrolling interest | 7.1 | 6.7 |
Total Stockholders' Equity | 12,378.6 | 12,027.0 |
Total Liabilities and Stockholders' Equity | $ 21,294.3 | $ 21,066.0 |